An Updated Review of Contribution of Long Noncoding Rna-Neat1 to the Progression of Human Cancers

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share By

An Updated Review of Contribution of Long Noncoding Rna-Neat1 to the Progression of Human Cancers Publisher Pubmed

Farzaneh M¹ ; Masoodi T² ; Ghaedrahmati F³ ; Radoszkiewicz K⁴ ; Anbiyaiee A⁵ ; Sheykhisabzehpoush M⁶ ; Rad NK⁷ ; Uddin S⁸ ; Jooybari SPM⁹ ; Khoshnam SE^{10, 11} ; Azizidoost S¹²

Source: Pathology Research and Practice Published:2023

Abstract

Long non-coding RNAs (lncRNAs) present pivotal roles in cancer tumorigenesis and progression. Recently, nuclear paraspeckle assembly transcript 1 (NEAT1) as a lncRNA has been shown to mediate cell proliferation, migration, and EMT in tumor cells. NEAT1 by targeting several miRNAs/mRNA axes could regulate cancer cell behavior. Therefore, NEAT1 may function as a potent biomarker for the prediction and treatment of some human cancers. In this review, we summarized various NEAT1-related signaling pathways that are critical in cancer initiation and progression. © 2023

Related Docs

View other Related Docs

1. The Role of Long Noncoding Rnas in Amyotrophic Lateral Sclerosis, Reviews in the Neurosciences (2024)

2. Critical Role of the Long Non-Coding Rnas (Lncrnas) in Radiotherapy (Rt)-Resistance of Gastrointestinal (Gi) Cancer: Is There a Way to Defeat This Resistance?, Pathology Research and Practice (2024)

3. Long Non-Coding Rnas: Potential Players in Cardiotoxicity Induced by Chemotherapy Drugs, Cardiovascular Toxicology (2022)

Experts (# of related papers)

View all Related Experts

Nima Rezaei (1)

Mohammad Hossein Ghahremani (1)

Other Related Docs

4. Identification of Key Lncrnas Associated With Oxaliplatin Resistance in Colorectal Cancer Cells and Isolated Exosomes: From In-Silico Prediction to In-Vitro Validation, PLoS ONE (2024)

5. Potential Roles of Lncrna-Xist/Mirnas/Mrnas in Human Cancer Cells, Clinical and Translational Oncology (2023)

6. Diagnostic, Prognostic, and Therapeutic Significance of Mir-139-5P in Cancers, Life Sciences (2020)

7. An Overview of Long Noncoding Rnas: Biology, Functions, Therapeutics, Analysis Methods, and Bioinformatics Tools, Cell Biochemistry and Function (2022)

8. Emerging Roles of Long Non-Coding Rna Ftx in Human Disorders, Clinical and Translational Oncology (2023)

9. Regulation of Long Non-Coding Rnas by Plant Secondary Metabolites: A Novel Anticancer Therapeutic Approach, Cancers (2021)

10. Non-Coding Rnas and Glioblastoma: Insight Into Their Roles in Metastasis, Molecular Therapy Oncolytics (2022)

11. Long Non-Coding Rnas and Melanoma: From Diagnosis to Therapy, Pathology Research and Practice (2023)

12. Oncogenic Mirnas and Target Therapies in Colorectal Cancer, Clinica Chimica Acta (2020)

13. A Comprehensive Review of the Role of Lncrnas in Gastric Cancer (Gc) Pathogenesis, Immune Regulation, and Their Clinical Applications, Pathology Research and Practice (2023)

14. Lncrnas Roles in Chemoresistance of Cancer Cells, Current Molecular Medicine (2022)

15. Modulation of Cancer Cell Signaling by Long Noncoding Rnas, Journal of Cellular Biochemistry (2019)

16. Functions of the Snai Family in Chondrocyte-To-Osteocyte Development, Annals of the New York Academy of Sciences (2021)

17. Functions, Mechanisms, and Clinical Applications of Lncrna Linc00857 in Cancer Pathogenesis, Human Cell (2023)

18. Cdkn2b-As1 As a Novel Therapeutic Target in Cancer: Mechanism and Clinical Perspective, Biochemical Pharmacology (2023)

19. Long Non-Coding Rnas (Lncrnas); Roles in Tumorigenesis and Potentials As Biomarkers in Cancer Diagnosis, Experimental Cell Research (2022)

20. The Expression of Lncrnas Casc2, Neat1, Linc00299 in Breast Cancer Tissues and Their Relationship With the Xbp1 Splicing Rate in Iranian Patients During 2014–2019: A Cross-Sectional Study, Health Science Reports (2023)

Style	Citing Format
MLA	Farzaneh M, et al.. "An Updated Review of Contribution of Long Noncoding Rna-Neat1 to the Progression of Human Cancers." Pathology Research and Practice, vol. 245, no. , 2023, pp. -.
APA	Farzaneh M, Masoodi T, Ghaedrahmati F, Radoszkiewicz K, Anbiyaiee A, Sheykhisabzehpoush M, Rad NK, Uddin S, Jooybari SPM, Khoshnam SE, Azizidoost S (2023). An Updated Review of Contribution of Long Noncoding Rna-Neat1 to the Progression of Human Cancers. Pathology Research and Practice, 245(), -.
Chicago	Farzaneh M, Masoodi T, Ghaedrahmati F, Radoszkiewicz K, Anbiyaiee A, Sheykhisabzehpoush M, Rad NK, et al.. "An Updated Review of Contribution of Long Noncoding Rna-Neat1 to the Progression of Human Cancers." Pathology Research and Practice 245, no. (2023): -.
Harvard	Farzaneh M et al. (2023) 'An Updated Review of Contribution of Long Noncoding Rna-Neat1 to the Progression of Human Cancers', Pathology Research and Practice, 245(), pp. -.
Vancouver	Farzaneh M, Masoodi T, Ghaedrahmati F, Radoszkiewicz K, Anbiyaiee A, Sheykhisabzehpoush M, et al.. An Updated Review of Contribution of Long Noncoding Rna-Neat1 to the Progression of Human Cancers. Pathology Research and Practice. 2023;245():-.
BibTex	@article{ author = {Farzaneh M and Masoodi T and Ghaedrahmati F and Radoszkiewicz K and Anbiyaiee A and Sheykhisabzehpoush M and Rad NK and Uddin S and Jooybari SPM and Khoshnam SE and Azizidoost S}, title = {An Updated Review of Contribution of Long Noncoding Rna-Neat1 to the Progression of Human Cancers}, journal = {Pathology Research and Practice}, volume = {245}, number = {}, pages = {-}, year = {2023} }
RIS	TY - JOUR AU - Farzaneh M AU - Masoodi T AU - Ghaedrahmati F AU - Radoszkiewicz K AU - Anbiyaiee A AU - Sheykhisabzehpoush M AU - Rad NK AU - Uddin S AU - Jooybari SPM AU - Khoshnam SE AU - Azizidoost S TI - An Updated Review of Contribution of Long Noncoding Rna-Neat1 to the Progression of Human Cancers JO - Pathology Research and Practice VL - 245 IS - SP - EP - PY - 2023 ER -

Science Communicator Platform

Authors

Abstract